Allicin has also been identified as a potential preventive agent for obesity and related metabolic diseases by increasing the expression of brown adipocyte-specific genes such as UCP-1 through the KLF15 signaling cascade [40]. This evidence concerns the gene UCP1 and metabolic disease.